|
54
Дерматовенерология и эстетическая меДицина № 3/2015
19. Ehrlich H.P., Desmouliere a., Diegelmann r.F.
et al. morpho-logical and immunochemical
differences between keloid and hypertrophic
scars // am j Pathol. 1994. 145; 105–113.
20. bock O., mrowietz u. Keloide — Eine dermale
fibro-proliferative
erkrankung
unbekannter
ursache // Der Hautarzt. 2002. 53; 515–523.
21. Clore j.n., Cohen I.K. and Diegelmann r.F.
Quantitative assays of types I and III collagen
synthesized by keloid biopsies and fibroblasts
// biochem biophys acta. 1979. 586; 384–390.
22. butler P.D., longaker m.T., yang G.P. Current
progress in keloid research and treatment // j
am Coll Surg. 2008. 206; 731–741.
23. robles D.T., moore E., Draznin m., berg D.
Keloids: pathophysiology and management
// Dermatol Online j. 2007. 13; 9.
24. baisch a., riedel F. Hyperplastic scars and
keloids: part I: basics and prevention // HnO.
2006. 54; 893–905.
25. alhady S.m. and Sivanantharajah K. Keloids
in various races. a review of 175 cases // Plast
reconstr Surg. 1969. 44; 564–566.
26. marneros a.G., norris j.E., Watanabe S. et
al. Genome scans provide evidence for keloid
susceptibility loci on chromosomes 2q23 and
7p11 // j Invest Dermatol. 2004. 112; 1126–1132.
27. rossi a., bozzi m. Hla and keloids: antigenic
frequency and therapeutic response // G Ital
Dermatol Venereol. 1989. 124; 341–344.
28. lu W.S., Wang j.F., yang S. et al. association
of Hla-DQa1 and DQb1 alleles with keloids in
Chinese Hans // j Dermatol Sci. 2008. 52; 108–
117.
29. bayat a., bock O., mrowietz u., Ollier W.E.,
Ferguson m.W. Genetic susceptibility to keloid
disease and transforming growth factor beta
2 polymorphisms // br j Plast Surg. 2002. 55;
283–286.
30. bayat a., bock O., mrowietz u., Ollier W.E.,
Ferguson m.W. Genetic susceptibility to keloid
disease and hypertrophic scarring: transforming
growth factor beta 1 common polymor-phisms
and plasma levels // Plast reconstr Surg. 2003.
111; 535–543.
31. bayat a., bock O., mrowietz u., Ollier W.E.,
Ferguson m.W. Genetic susceptibility to keloid
disease: transforming growth factor beta receptor
gene polymorphisms are not associated with
keloid disease // Exp Dermatol. 2004. 13; 120–
124.
32. bayat a., Walter j.m., bock O., et al. Genetic
susceptibility to keloid disease: mutation
screening of the TGFbeta3 gene // br j Plast
Surg. 2005. 58; 914–921.
33. Teofoli P., barduagni S., ribuffo m. et al.
Expression of bcl-2, p53, c-jun and c-fos
protooncogenes in keloids and hypertrophic
scars // j Dermatol Sci. 1999. 22; 31–37.
34. Tanaka a., Hatoko m., Tada H. et al. Expression
of p53 family in scars // j Dermatol Sci. 2004.
34; 17–24.
35. Satish l., lyons-Weiler j., Hebda P.a., Wells
a. Gene expression patterns in isolated keloid
fibroblasts // Wound repair regen. 2006. 14;
463–470.
36. lim C.P., Phan T.T., lim I.j., Cao X. Stat 3
contributes to keloid pathogenesis via promoting
collagen production, cell proliferation and
migration // Oncogene. 2006. 25; 5416–5425.
37. appleton I., brown n.j., Willoughby D.a.
apoptosis, necrosis and proliferation: possible
implication in the etiology of keloids // am j
Pathol. 1996. 149; 1441–1447.
38. luo S., benathan m., raffoul W., Panizzon
r.G., Egloff D.V. abnormal balance between
proliferation and apoptotic cell death in
fibroblasts derived from keloid lesions // Plast
reconstr Surg. 2001. 107; 87–96.
39. Sayah D.n., Soo C., Shaw W.W. et al.
Downregulation of apoptosis-related genes in
keloid tissues // j Surg res. 1999. 87; 209–216.
40. messadi D.V., le a., berg S., jewett a., Wen Z.,
Kelly P., bertolami C.n. Expression of apoptosis-
associated genes by human dermal scar fibro-
blasts // Wound repair regen. 1999. 7; 511–517.
41. Seifert O., bayat a., Geffers r., Dienus K., buer
j., lцfgren S., matussek a. Identification of
unique gene expression patterns ithin different
lesional sites of keloids // Wound repair regen.
2008. 16; 254–265.
42. Cohen I.K., mcCoy b.j., mohanakumar T.,
Diegelmann r.F. Immunoglobulin, complement
and histocompatibility antigen studies in keloid
patients // Plast reconstr Surg. 1979. 63; 689–
695.
43. bloch E.F., Hall m.G. jr, Denson m.j., Slay-
Solomon V. General immune activity in keloid
patients // Plast reconstr Surg. 1984. 73; 448–
451.
44. Kazeem a.a. The immunological aspects of
keloidal tumor formation // j Surg Oncol. 1988.
38; 16–18.
45. Kischer C.W., Shetlar m.r., Shetlar C.l. and
Chrapil m. Immuno-globulins in hypertrophic
scars and keloids // Plast reconstr Surg. 1983.
71; 821–825.
46. Placik O.j. and lewis V.l. jr. Immunologic
associations of keloids // Surg Gynecol Obstet.
1992. 175; 185–193.
47. Diegelmann r.F., Evans m.C. Wound healing: an
overview of acute, fibrotic and delayed healing //
Front biosci. 2004. 9; 283–289.
48. artuc m., Hermes b., Steckelings u.m., Grutzkau
a., Henz b.m. mast cells and their mediators in
cutaneous wound healing-active participants or
innocent bystanders? // Exp Dermatol. 1999. 8;
1–16.
Do'stlaringiz bilan baham: |
